InsiderDB
Sign inStart free trial
Traded 9 days before earnings

Rep. Gilbert Ray Cisneros, Jr. bought Eli Lilly and Company (LLY)

Rep. Gilbert Ray Cisneros, Jr. (D-CA-31) · $1K–$15K · traded Oct 20, 2026

Traded before earnings

Eli Lilly and Company reported its results on Oct 29, 2026, 9 days after this trade. See the SEC filing ↗

Companies usually announce these dates ahead of time. Trading before one isn’t evidence the member knew the results.

Transaction
Bought
Amount
$1K–$15K
Owner
Not stated
Traded
Oct 20, 2026
Disclosed
Nov 10, 2026
Days to disclose
21
Asset type
Stock
As filed
Eli Lilly and Company Common Stock
Industry
Drug Manufacturers - General · Healthcare
Official filing ↗All of Cisneros's tradesAll Congress trades in LLY

Other trades in this filing

All of Cisneros's trades →

Recent Congress trades in LLY

Company context for LLY

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. LLYContract award·USAspending

    LLY: Department of Veterans Affairs contract award

    AMYVID_BETA AMYLOID IMAGING

    First observed: Nov 8, 2026, 7:28 PM ESTEvent / period: Aug 17, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  2. LLYRegulatory notice·Federal Register

    Foreign-Trade Zone 72; Application for Subzone Expansion; Eli Lilly and Company; Brownsburg, Lebanon, and Whitestown, Indiana

    A Notice notice explicitly mentions the company. Read the cited text for its role.

    Public: Nov 2, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  3. LLYFinancial report·SEC EDGAR

    LLY: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Oct 29, 2026, 11:35 AM EDTEvent / period: Sep 30, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.